[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doctor-en-li-xianxin":3,"doctor-lang-ok-en-li-xianxin":94},{"id":4,"slug":5,"name":6,"credentials":7,"titles":8,"specialtyName":11,"hospitalName":12,"spokenLanguages":13,"avatarSource":16,"detailHeroSource":17,"clinicalTags":18,"clinicalFocus":36,"expertise":37,"currentPosition":38,"department":11,"academicRole":39,"academicRoleDesc":40,"credentialsList":41,"educations":46,"publications":62,"locations":86,"seoTitle":92,"seoDescription":93},8,"li-xianxin","Li Xianxin","PhD in Medicine",[9,10],"Chief Physician","Professor","Urology","Shenzhen Qianhai Taikang Hospital",[14,15],"English","Mandarin","https:\u002F\u002Fatt.lumalinkglobal.com\u002Fcarepath\u002Fdoctor\u002Fbabec921-68df-46e1-9f3f-2df60295162a.png","https:\u002F\u002Fatt.lumalinkglobal.com\u002Fcarepath\u002Fdoctor\u002F89e7bc27-2b3d-48f7-b2cd-ffcc6631c161.png",{"conditions":19,"procedures":27},[20,21,22,23,24,25,26],"Prostate Cancer","Bladder Cancer","Kidney Cancer","Benign Prostatic Hyperplasia","Adrenal Disorders","Male Infertility","Sexual Dysfunction",[28,29,30,31,32,33,34,35],"Radical Prostatectomy","Radical Cystectomy","Ileal Neobladder Reconstruction","Minimally Invasive Prostate Surgery","Adrenal Surgery","Urologic Cancer Surgery","Male Infertility Treatment","- Sexual Dysfunction Treatment 其中 Urogenital Malignancies 属于总标签，已经填写前列腺",[20,21,28],"\u003Cp>Professor Xianxin Li has three decades of experience in urology, urologic oncology and andrology. His clinical strengths include the early diagnosis and surgical treatment of urogenital malignancies, minimally invasive management of benign prostatic hyperplasia, adrenal surgery and comprehensive care for male infertility and sexual dysfunction. He is experienced in complex procedures such as radical prostatectomy and radical cystectomy with ileal neobladder reconstruction. Advanced clinical and research training at the University of California, San Francisco and Osaka University supports his emphasis on precise diagnosis, minimally invasive surgery, organ function and individualized treatment planning.、\u003C\u002Fp>","Vice President","Doctoral Supervisor in Urology","Urologic oncology and andrology research and education",[42,43,44,45],"Chair, Andrology Branch, Shenzhen Medical Association","Vice Chair, Andrology Branch, Guangdong Medical Association","Vice Chair, Men's Health Management Branch, Guangdong Health Management Association","Member, Urogenital Oncology Committee, Guangdong Anti-Cancer Association",[47,52,57],{"year":48,"title":49,"institution":50,"description":51},2007,"Advanced Clinical and Research Training in Urologic Oncology","University of California, San Francisco and Osaka University","Undertook clinical and research training in urologic oncology at UCSF and Osaka University.",{"year":53,"title":54,"institution":55,"description":56},2005,"Elite Physician Program","Chinese Urological Association","Association | Completed the Elite Physician Program organized by the Chinese Urological Association in 2005.",{"year":58,"title":59,"institution":60,"description":61},2002,"Specialty standardized clinical training","Peking University Health Science Center","Completed specialty standardized clinical training at Peking University Health Science Center between 2000 and 2002.",[63,67,71,75,79,83],{"title":64,"journal":65,"year":66},"FAM64A is an androgen receptor-regulated feedback tumor promoter in prostate cancer","Cell Death & Disease",2021,{"title":68,"journal":69,"year":70},"miR-216b Post-Transcriptionally Downregulates Oncogene KRAS and Inhibits Cell Proliferation and Invasion in Clear Cell Renal Cell Carcinoma","Cellular Physiology and Biochemistry",2018,{"title":72,"journal":73,"year":74},"Aberrant expression of KPNA2 is associated with a poor prognosis and contributes to OCT4 nuclear transportation in bladder cancer","Oncotarget",2016,{"title":76,"journal":77,"year":78},"Frequent mutations of genes encoding ubiquitin-mediated proteolysis pathway components in clear cell renal cell carcinoma","Nature Genetics",2012,{"title":80,"journal":81,"year":82},"Comparative mRNA and microRNA expression profiling of three genitourinary cancers reveals common hallmarks and cancer-specific molecular events","PLOS ONE",2011,{"title":84,"journal":81,"year":85},"Integrated profiling of microRNAs and mRNAs: microRNAs located on Xq27.3 associate with clear cell renal cell carcinoma",2010,[87],{"institution":12,"address":88,"latitude":89,"longitude":90,"isPrimary":91},"No. 3099 Menghai Avenue, Nanshan Subdistrict, Qianhai Shenzhen-Hong Kong Modern Service Industry Cooperation Zone, Shenzhen, Guangdong Province, China","22.516998","113.896874",true,"Dr. Li Xianxin - Urology & Oncology Expert","Professor Xianxin Li is a leading expert in urology, urologic oncology, and andrology with 30 years of experience.",{"en":91}]